IO Biotech Inc (IOBT)

NASDAQ
4.85
+0.23(+4.98%)
  • Volume:
    15,986
  • Day's Range:
    4.59 - 4.86
  • 52 wk Range:
    3.56 - 17.88

IOBT Overview

Prev. Close
4.62
Day's Range
4.59-4.86
Revenue
-
Open
4.83
52 wk Range
3.56-17.88
EPS
-
Volume
15,986
Market Cap
133.13M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
42,038
P/E Ratio
-
Beta
-
1-Year Change
-
Shares Outstanding
28,815,267
Next Earnings Date
Aug 31, 2022
What is your sentiment on IO Biotech?
or
Market is currently closed. Voting is open during market hours.

IO Biotech Inc News

IO Biotech Inc Company Profile

IO Biotech Inc Company Profile

Employees
32

IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating cancer therapies based on the T-win technology platform. The company’s lead product candidate, IO102-IO103, which is designed to target immunosuppressive proteins, such as Indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in phase 2 clinical trial to treat melanoma, as well as in phase 1 clinical trial to treat lung, head and neck, bladder, and melanoma cancer. It also develops IO112, a product candidate that contains a single Arginase 1-derived peptide designed to target T cells that recognize epitopes derived from Arginase 1 for the treatment of cancers. The company was incorporated in 2014 and is based in Copenhagen, Denmark.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuyNeutralSellSell
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong SellSell
SummaryStrong BuyStrong BuyBuyStrong SellSell